• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Rhode Island House Passes Bill To Decriminalize Psilocybin

Microdose NewsDesk by Microdose NewsDesk
June 14, 2023
in Law & Politics
Reading Time: 2 mins read
A A

Rhode Island is moving closer to psychedelics medicine reform as the House of Representatives passed a bill this week to decriminalize possession and cultivation of psilocybin mushrooms.

The new law would remove criminal penalties for possessing and cultivating psilocybin for personal use (up to one ounce) and would be able to share that amount with other adults. The legislation passed on the floor with a clear majority vote of 54-11.

“This is a step toward addressing mental health treatment in a modern way based on evidence and research,” Rep. Brandon Potter, one of the bill’s sponsors said. “Psilocybin can be used safely, both recreationally and therapeutically, and for our veterans and neighbors who are struggling with chronic PTSD, depression and addiction, it can be a valuable treatment tool.”

The bill also has a framework for legalization, saying that if the Food and Drug Administration (FDA) reschedules psychedelics then the Rhode Island Department of Health “shall establish rules and regulations pertaining to cultivation, distribution and medical prescription.”

The bill now goes to the Senate for consideration, where state senators have been working on their own decrim measures.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Incredibly grateful to my colleagues in the @RIHouseofReps for supporting my legislation to decriminalize psilocybin.

This is a positive step toward addressing mental healthcare with modern, evidence-based policy and research. pic.twitter.com/WOxNQYpI4J

— Brandon Potter (@BrandonPotterRI) June 12, 2023

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

 

In other decrim news, Nevada is also getting closer to psychedelic medicine reform. As reported in Marijuana Moment

Buy Lasix Direct

, last week the Nevada legislature gave final approval to create a working group to study psychedelics and develop a plan for regulated access for therapeutic purposes.The bill is now awaiting approval from the governor’s desk.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Decriminalization
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
Chacruna Publishes Article Challenging DEA Ayahuasca Report

Chacruna Publishes Article Challenging DEA Ayahuasca Report

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.